Dublin, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/c2...nucleotide ) has announced the addition of the "Oligonucleotide Synthesis Market by Product & Services, Application, End-User - Global Forecast to 2020" report to their offering. Major factors driving the growth of this market include increasing R&D expenses in pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology also play a vital role in the development of this market. In addition, emerging Asian markets and the growing field of NGS have opened an array of opportunities for players in the oligonucleotide synthesis market. However, price erosion and lack of regulations for therapeutic oligonucleotides could hinder the growth of this market. Geographically, North America is expected to dominate the market in 2015, followed by Europe. However, the Asia-Pacific oligonucleotide synthesis market is slated to grow at the highest CAGR owing to the growing availability of synthesized oligos, increase in R&D funding and activities, and increasing focus of prominent players in in the APAC region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Oligonucleotide Synthesis Market, By Products & Services 8 Oligonucleotide Synthesis Market, By Application 9 Oligonucleotide Synthesis Market, By End User 10 Regional Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bioautomation Corporation - Biosearch Technologies, Inc. - Eurofins Genomics - Eurogentec S.A. - Gen9, Inc. - Genedesign, Inc. - General Electric Company (Ge) - Genscript Usa Inc. - Integrated Dna Technologies, Inc. (Idt) - Nitto Denko Avecia Inc. (Avecia) - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. - Trilink Biotechnologies, Inc. For more information visit http://www.researchandmarkets.com/research/c2...nucleotide
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
